Vol 2019, No 4 (2019)

Table of Contents

Research & Development

Lilly Affirms Immunology Interest with US$605 M ImmuNext Deal Abstract pdf html
Michelle Liu
Regeneron Forms Second RNAi Partnership with Alnylam Abstract pdf html
Michelle Liu
Gilead Looks to Machine Learning with insitro NASH Collaboration Abstract pdf html
Michelle Liu

Licensing

AstraZeneca Partners Again with Daiichi Sankyo for its ADC Cancer Treatment Abstract pdf html
Michelle Liu

Mergers & Acquisitions

Novartis Boosts Immunology Investment with IFM Tre Acquisition Abstract pdf html
Michelle Liu

Opinion & Analysis

IQVIA Pharma Deals: Review of 2018 Abstract pdf
Michelle Liu, Natasha Piper, Heather Cartwright & Taskin Ahmed


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.